☆ 4.6 Article

Management and treatment outcome of DRESS patients in Europe: An international multicentre retrospective study of 141 cases

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Review Allergy

Drug-Induced Hypersensitivity Syndrome (DIHS)/Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS): Clinical Features and Pathogenesis

Natsumi Hama et al.

Summary: Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms (DIHS/DRESS) is a severe delayed T-cell-mediated adverse drug reaction characterized by fever, rash, facial edema, organ involvement, and hematological abnormalities. DIHS/DRESS is associated with the reactivation of chronic persistent human herpesviruses and has a high mortality rate. Identifying potential drug causes and avoiding structurally related drugs is essential. Systemic corticosteroids are the mainstay of treatment with alternative options such as immunosuppressants. HLA class I alleles have been linked to DIHS/DRESS predisposition, providing insights into prevention, risk stratification, and early diagnosis.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2022)

添加到收藏夹

Editorial Material Allergy

Targeting interleukin-5 with benralizumab: A novel treatment for drug rash with eosinophilia and systemic symptoms

Emanual Maverakis et al.

ALLERGY (2022)

添加到收藏夹

Letter Allergy

Benralizumab for severe DRESS in two COVID-19 patients

Peter Schmid-Grendelmeier et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2021)

添加到收藏夹

Review Biochemistry & Molecular Biology

Current Perspective Regarding the Immunopathogenesis of Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms (DIHS/DRESS)

Fumi Miyagawa et al.

Summary: DIHS/DRESS is a severe adverse drug reaction involving multiorgan involvement and human herpesvirus reactivation, which can lead to fatal complications. CD4 and CD8 T cells play distinct roles in the pathogenesis of DIHS/DRESS, with CD4 T cells initiating drug allergies and herpesvirus-specific CD8 T cells causing tissue damage.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

添加到收藏夹

Article Dermatology

Impact of systemic to topical steroids switch on the outcome of drug reaction with eosinophilia and systemic symptoms (DRESS): A monocenter retrospective study of 20 cases

C. Brin et al.

Summary: The study investigated the short-term outcome of patients with DRESS who initially received SS therapy before being transferred to dermatology department and switched to TS. It was found that caution is needed when managing severe cases with initial SS therapy to avoid rapid switch to TS and risk of relapse.

ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE (2021)

添加到收藏夹

Article Dermatology

Discriminating minor and major forms of drug reaction with eosinophilia and systemic symptoms: Facial edema aligns to the severe phenotype

Sophie Elizabeth Momen et al.

Summary: By analyzing clinical and dermatopathologic features of hospitalized DRESS patients, it was found that factors such as latency period, fever, reaction duration, facial edema, basal squamatization, dermal red blood cell extravasation, and interface inflammation can help distinguish between mild and severe forms of the disorder.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2021)

添加到收藏夹

Editorial Material Hematology

Hematologic findings in drug reaction with eosinophilia and systemic symptoms (DRESS)

Tatsiana Pukhalskaya et al.

AMERICAN JOURNAL OF HEMATOLOGY (2021)

添加到收藏夹

Letter Allergy

Benralizumab: A potential tailored treatment for life-threatening DRESS in the COVID-19 era

Farah Mesli et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2021)

添加到收藏夹

Article Dermatology

Drug reaction with eosinophilia and systemic symptoms may occur within 2 weeks of drug exposure: A retrospective study

Angele Soria et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2020)

添加到收藏夹

Article Allergy

Spanish Guidelines for Diagnosis, Management, Treatment, and Prevention of DRESS Syndrome

R. Cabanas et al.

JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY (2020)

添加到收藏夹

Article Dermatology

Influence of corticosteroid therapy on viral reactivation in drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms

Mikiko Tohyama et al.

JOURNAL OF DERMATOLOGY (2020)

添加到收藏夹

Letter Dermatology

Comment on Viral reactivation in hospitalized DRESS patients: A retrospective study from a tertiary medical center in the United States

Yung-Tsu Cho et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2020)

添加到收藏夹

Letter Dermatology

Viral reactivation in hospitalized patients with drug reaction with eosinophilia and systemic symptoms: A retrospective study from a tertiary medical center in the United States

Nima Milani-Nejad et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2020)

添加到收藏夹

Article Dermatology

Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms severity score: A useful tool for assessing disease severity and predicting fatal cytomegalovirus disease

Yoshiko Mizukawa et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2019)

添加到收藏夹

Review Allergy

Drug-induced hypersensitivity syndrome (DiHS)/drug reaction with eosinophilia and systemic symptoms (DRESS): An update in 2019

Tetsuo Shiohara et al.

ALLERGOLOGY INTERNATIONAL (2019)

添加到收藏夹

Letter Dermatology

Expert opinion on DRESS and viruses: Answer

V. Descamps

ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE (2018)

添加到收藏夹

Article Dermatology

Treatment of severe cutaneous adverse drug reactions

S. Ingen-Housz-Oro et al.

ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE (2018)

添加到收藏夹

Review Immunology

Recent Advances in Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms

Hideaki Watanabe

JOURNAL OF IMMUNOLOGY RESEARCH (2018)

添加到收藏夹

Article Dermatology

Prevalence, risk factors, and mortality outcome in the drug reaction with eosinophilia and systemic symptoms patients with cardiac involvement

Julphat Intarasupht et al.

INTERNATIONAL JOURNAL OF DERMATOLOGY (2018)

添加到收藏夹

Review Medicine, General & Internal

Severe cutaneous adverse reactions to drugs

Tu Anh Duong et al.

LANCET (2017)

添加到收藏夹

Article Dermatology

Cyclosporine Treatment of Drug-Induced Hypersensitivity Syndrome

Mark G. Kirchhof et al.

JAMA DERMATOLOGY (2016)

添加到收藏夹

Article Dermatology

Therapeutic management of DRESS: A retrospective study of 38 cases

Elisa Funck-Brentano et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2015)

添加到收藏夹

Article Dermatology

Long-term sequelae of drug reaction with eosinophilia and systemic symptoms: A retrospective cohort study from Taiwan

Yi-Chun Chen et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2013)

添加到收藏夹

Article

Poor Benefit/Risk Balance of Intravenous Immunoglobulins in DRESS

Baptiste Janela

ARCHIVES OF DERMATOLOGY (2012)

添加到收藏夹

Article Genetics & Heredity

Toxic epidermal necrolysis, DRESS, AGEP: Do overlap cases exist?

Sophie Bouvresse et al.

ORPHANET JOURNAL OF RARE DISEASES (2012)

添加到收藏夹

Article Dermatology

Management of drug reaction with eosinophilia and systemic symptoms (DRESS)

V. Descamps et al.

ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE (2010)

添加到收藏夹

Article Dermatology

Twelve-Year Analysis of Severe Cases of Drug Reaction With Eosinophilia and Systemic Symptoms A Cause of Unpredictable Multiorgan Failure

Majed Eshki et al.

ARCHIVES OF DERMATOLOGY (2009)

添加到收藏夹

Review Allergy

A complex interaction between drug allergy and viral infection

Tetsuo Shiohara et al.

CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2007)

添加到收藏夹

Letter Dermatology

Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?

S. H. Kardaun et al.

BRITISH JOURNAL OF DERMATOLOGY (2007)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.